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Aging is a natural and gradual process in human life. It is 
influenced by heredity, environment, lifestyle, and disease. 
DNA methylation varies with age, and the ability to predict the 
age of donor using DNA from evidence materials at a crime 
scene is of considerable value in forensic investigations. 
Recently, many studies have reported age prediction models 
based on DNA methylation from various tissues and body 
fluids. Those models seem to be very promising because of 
their high prediction accuracies. In this review, the changes of 
age-associated DNA methylation and the age prediction models 
for various tissues and body fluids were examined, and then 
the applicability of the DNA methylation-based age prediction 
method to the forensic investigations was discussed. This will 
improve the understandings about DNA methylation markers 
and their potential to be used as biomarkers in the forensic 
field, as well as the clinical field. [BMB Reports 2017; 50(11): 
546-553]
INTRODUCTION
Aging is a universal phenomenon that occurs in most living 
organisms and is one of humanity's greatest concerns. Aging is 
defined as the time-dependent functional decline, which is 
thought to be associated with various molecular modifications 
in cells that accumulate over a person’s lifetime (1). Since the 
isolation of the first long-lived strains from Caenorhabditis 
elegans in 1983 (2), extensive aging studies have been 
conducted with a constantly expanding knowledge of the 
molecular and cellular mechanisms of life and disease (3). 
There have been many theories and doctrines to explain the 
cause and mechanism of aging, but the fact that there is no 
single theory that can explain aging clearly indicates the 
complexity and diversity of the aging process. As a step 
towards understanding the aging process, efforts have been 
made to identify and categorize the cellular and molecular 
features of aging. In 2013, nine hallmarks of aging were 
enumerated by Lopez-Otín et al., and the nine hallmarks are 
genomic instability, telomere attrition, epigenetic alterations, 
loss of proteostasis, deregulated nutrient sensing, mitochondrial 
dysfunction, cellular senescence, stem cell exhaustion, and 
altered intercellular communication (3). Since these features 
appear simultaneously during the aging process and are 
interconnected, identifying the precise causal relationship 
among them is an important challenge.
Epigenetic alteration is a change in the patterns of epigenetic 
modifications. Epigenetics is most commonly defined as the 
modification of DNA and DNA packaging without any change 
in DNA sequence (4), and plays an important role in various 
biological processes such as silencing of gene expression or 
maintaining of genomic stability, thereby implying that it may 
influence other hallmarks of aging. The epigenetic mark that 
has been most comprehensively studied is DNA methylation. 
DNA methylation involves the addition of a methyl group to 
the 5’ cytosine of CG dinucleotide, referred to as CpGs. DNA 
methylation is related to gene regulation and cell differentiation 
by affecting transcription factor binding sites, insulator com-
ponents, and chromosome morphology (5, 6). In the human 
genome, 70-80% of the total CpG is methylated and most of 
the unmethylated CpG is clustered in the CpG island at the 5’ 
end of the genes (7). Factors underlying variable DNA methy-
lation include cell differentiation, aging, genetic variation and 
environmental exposures such as diet, smoking, sunlight, UV 
radiation, pathogen infection, exercise, alcohol consumption, 
stress, etc. A pioneer study on DNA methylation and aging 
revealed that 5-methylcytosine (5mC) levels dramatically 
decreased during ontogenesis through the investigation of 
different organs and life stages of the humpback salmon (8). 
Such an age-related global DNA hypomethylation has been 
also observed in a variety of species, including rats (9), mice 
(10), and humans (11). However, some genes become hyper-
methylated with age, including Polycomb group protein target 
genes known to have roles in chromatin remodeling related 
with gene silencing (12). The advent of microarray and 
massive parallel sequencing technologies (MPS) in epigenetics 
enabled the detection of more specific age-associated DNA 
methylation changes at certain genes or genomic regions. 
Several recent studies used methylation measures at multiple 
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Fig. 1. Schematic representation of epigenetic drift versus the 
epigenetic clock. If a specific CpG site is associated with age 
(top) within an individual, it may be undergoing either epigenetic 
drift (left) or an epigenetic clock site (right). Both phenomena have
different characteristics when examined across a population or 
within a twin set. Reprinted from Jones et al. (28) with permission
from John Wiley & Sons Ltd. and The Anatomical Society.
CpG sites that are highly associated with age to predict 
chronological age in humans. 
Age prediction based on DNA methylation is now attracting 
attention, especially in the field of forensic genetics because it 
has been known to be the most accurate method to predict 
age and can contribute to solving crimes by narrowing down 
the search range of unknown suspects or missing people. In 
this review, we would like to focus on DNA methylation- 
based age predictive models and their potential applicability to 
the forensic field. More specifically, we will discuss age 
predictive models that could be applied to the forensically 
relevant tissues and body fluids such as blood, saliva, semen 
and skeletal remains.
BIOLOGICAL BACKGOUND OF AGE-ASSOCIATED 
DNA METHYLATION CHANGES
DNA methylation changes with aging
Early studies based on immune, colorimetric and HPLC analysis 
have shown that the global DNA methylation decreases with 
age (10, 13, 14). More recent studies reveal that the overall 
DNA methylation level of the genome increases throughout 
the first year of life and then stabilizes through adulthood to 
advanced age in blood (15-18). Postadulthood, median global 
DNA methylation decreases as the aging process progresses, 
and interindividual variability increases over time (10, 13, 14). 
However, the rate of aging depends mainly on the person, 
mostly appearing differently depending on the genetic, 
environment and lifestyle (19). Twin studies have indicated 
that variability in DNA methylation increases with age while 
showing that the genetic changes affecting human aging are 
only about 20 to 30% (20, 21). Other studies have shown that 
DNA methylation associated with age is dependent on gender, 
obesity index, and specific tissues or cells (17, 22-24). Recent 
studies, based on microarray and MPS analysis, confirm a 
global methylation decreases with age, but show age- 
associated increase or decrease in DNA methylation levels at 
specific loci (25).
Epigenetic drift and epigenetic clock
Age-related DNA methylation changes have been described as 
two phenomena: the epigenetic drift and the epigenetic clock 
(26). Epigenetic drift reflects the effects of environment in 
which a person ages, and explains the increase in discordance 
between human epigenomes with age. On the other hand, the 
sites of epigenetic clock show age-associated DNA methylation 
changes that are common across individuals, and can thus be 
used to predict an individual’s age (Fig. 1).
Since epigenetic drift comprises age-related changes that are 
acquired environmentally and stochastically (26-30), the 
specific site that undergoes epigenetic drift in one person does 
not likely show the same changes in another person. In 
contrast, epigenetic clock consistently occurs at the same site 
between individuals (26). The epigenetic clock sites have been 
identified both within a specific tissue and across various 
tissues. Several studies show that this characteristic can be 
tissue-specific (29). In effect, many age predictive models that 
are specific to a certain tissue or cell type have been reported 
and the model that can be applied across various tissues also 
shows different methylation age in different tissues (25).
DNA METHYLATION-BASED AGE PREDICTIVE 
MODELS
Multi-tissue age predictive models
The advent of microarray technology in the field of epigenetics 
helped drive a revolution in aging research by paving the way 
to identify specific CpG sites that are highly associated with 
age. As more and more DNA methylation profiles were pro-
duced using this microarray technology, attempts to identify 
and use age-associated CpG sites that are not cell or tissue 
type dependent for construction of the age predictive model 
have been made, even though the majority of age-associated 
DNA methylation changes are tissue-specific. 
Koch and Wagner (31) identified 19 CpG sites that are 
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hypermethylated with aging from five public data sets pro-
duced from 20-30 samples each of dermis, epidermis, uterine 
cervical smear, T-lymphocyte, and monocyte using Illumina’s 
HumanMethylation27 BeadChip array (Illumina 27K). Four of 
these sites including CpGs in the NPTX2, TRIM58, GRIA2, and 
KCNQ1DN genes, and another hypomethylation site in the 
BIRC4BP gene were selected to implement an age prediction 
and the predictive model showed an accuracy with a mean 
absolute deviation from chronological age (MAD) of 12.7 
years in eight validation sets. These sets were composed of 
766 samples including peripheral blood (PB) leukocytes, saliva, 
PB lymphocytes, CD34＋ hematopoietic progenitor cell, cord 
blood monocytes, PB monocytes, breast tissue, and buccal 
epithelial cells. However, breast tissue showed considerably 
lower DNA methylation than other cell types at the CpG site 
of the BIRC4BP gene and the prediction accuracy increased to 
11.4 years of MAD when age prediction was performed and 
focused on three most significant CpG sites in the KCNQ1DN, 
NPTX2, and GRIA2.
Horvath (25) also reported an age predictive model that can 
be applied across a broad spectrum of tissues and cells. The 
study developed a highly accurate model based on the analysis 
results of 7,840 non-cancer samples from 82 data sets pro-
duced using Illumina 27K or Illumina’s HumanMethylation450 
BeadChip array (Illumina 450K), which encompass 51 different 
tissues and cell types. Among the 82 data sets, 39 were used 
to train the model using a penalized multivariate regression 
method known as Elastic Net, 32 were used to validate the 
model and the rest were used for other purposes. In this report, 
a total of 21,369 CpGs that are present on both Illumina 27K 
and 450K, and had less than 10 missing values across the data 
sets were studied. The 353 CpGs that were automatically 
selected from the elastic net allowed highly accurate age 
prediction with a MAD of 2.9 years in the training data and a 
MAD of 3.6 years in the test data. The model performed 
efficiently in heterogeneous tissues and individual cell types. 
However, the interesting part of the study was that the data 
showed significant differences in methylation age from several 
tissues. A high error, i.e. MAD values of more than 10 years, 
was observed in breast tissue, uterine endometrium, dermal 
fibroblasts, skeletal muscle tissue, heart tissue and sperm. 
Although such phenomenon might attribute to the hormonal 
effects, menstrual cycle, stem cell recruitment or different cell 
lineage, it implied that there might exist specific sites within a 
tissue that would allow for a more accurate prediction of 
chronological age for that tissue (26). 
Age predictive models for blood
Many studies reported age-associated DNA methylation changes 
in blood, but there had been no age predictive model specific 
for blood until Hannum et al. (29) reported a quantitative 
model of aging using Illumina 450K data from the whole 
blood of 656 individuals aged 19 to 101. They proposed a 
new concept of age estimation by combining clinical variables 
such as sex and BMI with DNA methylation measures for 
better understanding of epigenetic drift underlying age- 
associated methylation changes. The model trained with both 
methylomic and clinical parameters from 482 individuals 
included 71 age-associated CpGs selected from elastic net 
regression. The prediction accuracy of the model was high 
with a MAD of 3.9 years in the training data and 4.9 years in 
the test data composed of 174 independent samples. It was 
interesting to note that most of the selected markers were in or 
near genes implicated in aging-related diseases or functional 
decreases. For example, six markers of this model laid within 
the transcription factor KLF14, known as a master regulator of 
obesity and other metabolic traits. In addition, the ELOVL2 
gene was highlighted again as a promising age predictor for 
blood since the first report, using Illumina 450K to identify 
age-associated CpGs by Garagnani et al. (32). 
Weidner et al. (18) was notable in terms of application 
because they demonstrated the possibility to predict an age 
with a high accuracy using only a few CpGs. They first 
selected 102 age-associated CpGs from Illumina 27K data of 
575 blood samples, and constructed an age predictive model 
with a MAD of 3.3 years. They further reduced the number of 
CpGs to three for model construction, while keeping the age 
prediction accuracy considerably high. They finally selected 
three CpGs of the ITGA2B, ASPA, and PDE4C genes in 
consideration of age predictability and feasibility to design 
primers for the following pyrosequencing analysis. The model 
composed of these three CpGs showed high accuracy with a 
MAD of 5.4 years in 82 training samples and a MAD of 4.5 
years in 69 test samples. The accuracy of age prediction of this 
model was lower than the models by Hovath (25) or Hannum 
et al. (29), but this approach had the merit of being cost 
effective and not requiring complicated bioinformatics. 
Utilizing only a few CpG sites is also appealing to forensic 
geneticists, because most of the casework samples do not 
provide enough amount of DNA for epigenome-wide analysis 
such as a microarray analysis. In the field of forensics, Zbieć- 
Piekarska et al. (33) reported simple, but a highly effective age 
prediction method that requires the analysis of only a specific 
genomic region in the ELOVL2 gene. They analyzed seven 
adjacent CpG sites in one fragment of the ELOVL2 gene by 
pyrosequencing and constructed an age predictive model 
using two most highly age-associated CpGs. The model showed 
a relatively high prediction accuracy with a MAD of 5.0 years 
in the training set of 303 samples and a MAD of 5.8 years in 
the test set of 124 samples. A total of 68.5% of test samples 
were within the range of chronological age ± 7 years, which 
corresponded to ± 1.0 Root Mean Square Error (RMSE). Later, 
they reported another age prediction method that was more 
accurate and based on the DNA methylation measures from 
pyrosequencing at five CpG sites, one each from the ELOVL2, 
C1orf132, TRIM59, KLF14, and FHL2 genes (34). The model 
demonstrated improved prediction accuracy in blood with a 
MAD of 3.4 years in the training set of 300 samples and a 
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MAD of 3.9 years in the test set of 120 samples. However, age 
prediction accuracy decreased in older age group, which 
reflected the increasing variation in DNA methylation from 
epigenetic drift with age. This model was further tested in 
another population of 100 Koreans and showed the very 
similar accuracy with a MAD of 4.2 years (35). This proved 
that the age prediction performance of the model was rela-
tively consistent across different population groups. 
Park et al. (36) also proposed a highly accurate model for 
age prediction in blood using only three CpGs, one from each 
of the genes, ELOVL2, ZNF423, and CCDC102B. They 
selected these three sites from Illumina 450K datasets of 1415 
individuals in consideration of feasibility to design primers for 
pyrosequencing analysis. The model trained with the DNA 
methylation values measured from pyrosequencing of 535 
blood samples was highly accurate with a MAD of 3.2 years, 
and produced prediction values with a MAD of 3.4 years from 
230 test set samples. Several other models based on different 
combination of age-associated markers and different analysis 
platforms such as EpiTyper or MPS have been reported to have 
high age predictability (37-39). Up to now the CpGs in the 
ELOVL2 gene, however, have been commonly accepted as the 
most powerful age predictor in blood. 
Age predictive models for saliva and buccal epithelial cells
The first DNA methylation-based age predictive model was 
proposed by Bocklandt et al. (22) using Illumina 27K data of 
saliva samples obtained from 34 twin pairs aged 21 to 55 
years. The model was composed of three age-associated CpGs 
of the EDARADD, NPTX2, and TOM1L1 genes and showed an 
average accuracy of 5.2 years. However, the CpG site in the 
NPTX2 gene did not show significant age correlation in 
another data set composed of 29 unrelated females and the 
model’s precision was not fully validated using an indepen-
dent set of samples. 
Hong et al. (40) reported an age predictive model for saliva 
that is composed of six age-associated CpGs of the SST, 
CNGA3, KLF14, TSSK6, TBR1, and SLC12A5 genes and a cell 
type-specific CpG marker of the PTPN7 gene. They selected 
these six age-associated CpG markers from the Illumina 450K 
data for 52 saliva samples. A linear regression analysis with 
age information and the methylation measures obtained from 
multiplex SNaPshot reaction in an independent set of 113 
training samples produced the model with an accuracy of 3.13 
years (MAD = 3.13 years, RMSE = 4.3 years). In a subsequent 
validation with 113 test set samples, this model also showed 
high prediction accuracy with a MAD of 3.15 years. On 
average, 70% of samples had an error between −1.0 and 
＋1.0 RMSEs, and 95% of samples had an error between −2.0 
and ＋2.0 RMSEs. 
Eipel et al. (41) also proposed to use cell type-specific CpGs 
for age prediction from buccal swab samples in combination 
with age-associated CpGs from blood (3 CpGs, one each in 
the genes PDE4C, ASPA, and ITGA2B). Their model was 
composed of two cell type-specific CpGs and three age- 
associated CpGs, and showed MADs of 5.09 years and 5.12 
years in two independent validation sets. Intriguingly, the 
methylation measures of the cell-specific marker of the PTPN7 
gene from Hong et al. (40) were highly correlated with the 
predicted epithelial cell compositions calculated using the 
“Buccal-Cell Signature” function from Eipel et al. (41). These 
two studies demonstrated the possibility to improve age 
prediction from tissues with a heterogeneous cell composition, 
by combining cell type-specific CpG markers and age- 
associated CpG markers. 
Age predictive models for other forensically-relevant tissues 
or body fluids
Lee et al. (42) proposed an age predictive model based on 
semen DNA methylation for the first time. Semen can provide 
important clues for solving sex crimes and it is one of the most 
forensically relevant body fluids. Lee et al. identified three 
age-associated CpGs (cg12837463 and two CpGs of the 
TTC7B and NOX4 genes) from Illumina 450K data for 12 
semen samples and an independent validation with methylation 
SNaPshot assay in 31 semen samples. Among these genes, the 
TTC7B gene demonstrated the highest association with age, 
and had been reported to show age-related DNA methylation 
changes in the longitudinal study of sperm methylome from 17 
fertile males (43). The linear regression model composed of 
the three CpGs showed relatively high prediction accuracy 
with MADs of 4.2 years and 5.4 years in the 31 training 
samples and 37 test samples, respectively. 
There were reports that applied age-associated CpGs from 
blood to age prediction in other forensically relevant tissues 
such as teeth (44, 45). Bekaert et al. (44) selected four CpGs of 
the ASPA, PDE4C, ELOVL2, and EDARADD genes from the list 
of age-associated CpGs from blood and demonstrated that the 
model constructed with DNA methylation measures at these 
four CpG sites from pyrosequencing analysis had a relatively 
high prediction accuracy with a MAD of 4.9 years in teeth 
samples from 29 individuals aged 19 to 70. Giuliani et al. (45) 
also analyzed the DNA methylation at the ELOVL2, FHL2, and 
PENK genes in the teeth using EpiTYPER system. They con-
structed age-predictive models separately for each teeth part, 
i.e., dental pulp, cimentum and dentin. Each model was 
composed of 5 to 13 CpGs from the ELOVL2, FHL2, and PENK 
genes, and produced MADs of 1.2 years when DNA was 
recovered from both cementum and pulp from the same tooth, 
2.3 years when DNA was recovered from dental pulp, 2.5 
years when DNA was extracted from cementum, and 7.1 years 
when DNA was recovered from dentin. Since each part of the 
teeth varied in the cell composition, these results could be 
expected. Dental pulp contains large nerve trunks and blood 
vessels, but dentin is a calcified tissue mostly composed of 
inorganic material.
DNA methylation-based age prediction
Sang Eun Jung, et al.
550 BMB Reports http://bmbreports.org
POSSIBLE APPLICATION OF DNA METHYLATION AGE
Clinical application of DNA methylation age 
There have been continued efforts to identify new risk factors 
that can improve the ability to predict disease and mortality. 
Because DNA methylation age, which is the predicted value 
from DNA methylation-based age prediction, has been ex-
pected to reflect biological age, Marioni et al. (46) tested 
whether the difference between DNA methylation age and 
chronological age (age) can predict mortality risk in later life. 
They calculated age in four longitudinal cohorts of older 
people using age predictive models by Hannum et al. (29) and 
Horvath (25). The correlations between chronological age and 
predicted age were 0.83 and 0.75 for the Hannum measure 
and the Horvath measure, respectively. The correlation 
between predicted ages for Hannum and Horvath was 0.77. In 
the meta-analyzed results, a 5-year higher age was associated 
with a 16% greater mortality risk after an adjustment for 
chronological age, sex, childhood IQ, education, social class, 
hypertension, diabetes, cardiovascular disease, and APOE e4 
status. A pedigree-based analysis of age indicated that approxi-
mately 40% of inter-individual differences in age were due to 
genetic factors. In addition, another test to examine the 
relationship between the two DNA methylation measures and 
exceptional longevity also showed that the long-lived 
individuals have a young DNA methylation age compared 
with their chronological age (47). These studies demonstrate 
DNA methylation age as a measure for biological age that is 
not always parallel with chronological age, but instead may 
inform life expectancy predictions (46). DNA methylation age 
might therefore be useful in the research to identify age 
accelerator or decelerator for extended human life span. 
Forensic application of DNA methylation age 
Although DNA methylation age is not always parallel with 
chronological age, close prediction of age can provide an 
important investigative lead to narrow down the search range 
for unknown suspects or victims. Therefore, there have been 
many reports on DNA methylation-based age prediction in the 
field of forensics. However, the samples collected from the 
crime scene frequently contain only a small amount of DNA, 
and tissue or body fluid type, where the DNA has originated 
from should be identified in advance for accurate age 
prediction. Thereby, choosing the most appropriate analytical 
method for forensic application is more difficult than in 
clinical application. Thus, there are several key factors to 
consider when choosing a method to predict an age based on 
DNA methylation measures for forensic purpose: 1) availa-
bility of age predictive model that is specific for a certain type 
of tissue or body fluid; 2) amount and quality of the DNA 
required for analysis; 3) accuracy of the method; 4) robustness 
and simplicity of the method; 5) availability of statistics for 
interpretation; 6) availability of specialized equipment and 
reagents; and 7) the cost.
The two representative models by Hannum et al. (29) and 
Horvath (25) have high prediction accuracy, and the model by 
Horvath has merit that can be applied to a broad spectrum of 
tissues. However, it does not seem feasible to apply these 
methods to casework samples because of their array-based 
epigenome-wide analysis platform that requires considerable 
amount of high quality DNA and complicated bioinfomatics. 
In contrast, the models that were constructed specific for 
forensically-relevant body fluids using DNA methylation 
measures obtained from targeted bisulfite sequencing such as 
pyrosequencing, EpiTyper, methylation SNaPshot, or MPS 
seem more promising to be easily incorporated into forensic 
procedures. These methods require smaller amounts of DNA 
than epigenome-wide analysis and provide reproducible 
highly accurate DNA methylation measures.
Pyrosequencing provides accurate and detailed profiles of 
DNA methylation patterns within 100 bases from the pyrose-
quencing primer binding site. This method is based on the 
“sequencing by synthesis” principle, and the sequence is 
determined by the detection of known nucleotide incorporation. 
The incorporation of nucleotide by a DNA polymerase appears 
as the light emission from luciferase that is proportional to the 
amounts of pyrophosphate released upon nucleotide incor-
poration. The degree of methylation at each CpG site in a 
sequence is determined from the ratio of nucleotides T and C. 
This technique is quantitative, and can detect low methylation 
differences of up to 5%, but does not allow multiplex assay 
(48).
EpiTYPER is a mass spectrometer-based bisulfite sequencing 
method that enables regional-specific DNA methylation analysis 
(49). This technique uses base-specific enzymatic cleavage 
coupled to MALDI-TOF mass spectrometry for analysis of 
bisulfite-converted DNA. Its fast, accurate analysis power and 
multichannel analysis capability are advantageous, but limited 
throughput and high cost restricts its wider application in the 
forensic field.
Methylation SNaPshot is based on the primer extension 
method that has been originally developed for SNP analysis. It 
is characterized by the analysis of bisulfite-converted DNA 
through single-nucleotide primer extension process, which 
uses a primer designed to be located up to 1 bp upstream of 
the CpG site (50). This method allows for multiplexed analysis, 
thereby saving DNA consumed for the assay. However, 
imbalance in intensities between the different fluorescent dyes 
of the SNaPshotⓇ kit may require adjustment to obtain 
accurate absolute measures for DNA methylation.
MPS-based targeted bisulfite sequencing is also increasingly 
used in the field of forensics (38, 39, 51). PCR fragments 
obtained from bisulfite-converted DNA can be used in the 
library preparation for MPS analysis. Characteristics such as 
high throughput and high sensitivity ensure its application in 
the forensic field, but it is still required to simplify the data 
analysis procedure to help researchers who are not familiar 
with big size data. 
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In addition, since DNA methylation age in the forensic field 
should provide the information about unknown person’s 
unknown age, the possible range of prediction deviation needs 
to be considered when data is reported (39, 40). Although 
RMSE is not as clear as MAD, it has other implications from an 
interpretation standpoint. Many distributions of error were 
known to follow the normal distribution and in case of a 
normal distribution, 68% of errors fall between −1.0 and 
＋1.0 RMSEs and 95% of errors fall between −1.96 and 
＋1.96 RMSEs (22, 40). Recent papers on DNA 
methylation-based age prediction (33, 39, 40) prove that the 
use of the 1.0 RMSE and 2.0 RMSE range is informative to 
predict the possible range of prediction deviation: Around 
70% samples fall into ± 1.0 RMSE range and 95% in the ± 
2.0 RMSE range. These papers applied different analysis 
platforms to measure DNA methylation, i.e., pyrosequencing 
(33), methylation SNaPshot (40), and MPS (39) respectively. 
Because the type of tissues and body fluids from the crime 
scene could be more diverse, the development of new models 
or the evaluation of a model specific for a certain type of tissue 
or body fluid in other types of tissues or body fluids would be 
beneficial for the future forensic applications of the DNA 
methylation-based age prediction method. Also, many casework 
samples could be present in a mixed form, so the method to 
isolate specific tissue or cell type needs to be considered for 
more accurate prediction of age. 
CONCLUSION 
The relationship between DNA methylation and aging has 
been described as the epigenetic drift and the epigenetic 
clock. Epigenetic drift increases the interindividual variation 
with age influenced by environmental factors. In contrast, 
epigenetic clock sites are highly associated with age across 
individuals, and thus can be used to predict chronological age. 
With an advent of microarray technology, more and more 
researchers reported age-associated DNA methylation markers 
and age predictive models. DNA methylation age predicted 
from DNA methylation measures at several to hundreds of 
CpG sites are expected to measure biological age that is not 
always parallel with chronological age but may provide 
information about life expectancy as well as unknown sample 
donor’s appearance. 
There exist models that can be applied across broad 
spectrum of tissues, but the age prediction accuracy varies 
depending on the tissue type. In the field of forensics, models 
for age prediction in blood, saliva, semen, buccal swabs, and 
teeth have been reported using only a few age-associated 
CpGs. The prediction accuracy of these models is high, with a 
MAD of less than 5 years. However, for a better application of 
these models, pros and cons of related analysis methods 
should be considered. In addition, efforts should be made not 
only to identify more age-associated DNA methylation markers 
for various tissues and cells, but also to develop standards and 
software for an accurate interpretation of quantitative analysis 
results. To forecast the possible range of prediction deviation, 
the RMSE is an appropriate measurement: Around 70% 
samples fall into ± 1.0 RMSE range and 95% in the ± 2.0 
RMSE range. In the future, it is expected that the age- 
associated DNA methylation markers and age predictive 
models will play an important role, not only in the forensic 
investigation, but also in clinical research to monitor health 
condition and to identify age decelerators for the longer life 
expectancy.
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